Alderley Analytical is revolutionizing bioanalysis by providing high-quality, interruption-free results to customers, ensuring the safe and efficient development of new drugs. Sally Hannam, Scientific Director at Synexa Life Sciences, praises the Xevo TQ Absolute XR Mass Spectrometer, ACQUITY™ Premier UPLC™ System, and waters_connect™ Software for their unparalleled reproducibility and accuracy in analyzing crashed human plasma. With over 20,000 injections analyzed, these technologies offer new levels of confidence in tackling complex bioanalysis applications and emerging modalities.By utilizing cutting-edge instrumentation like the Xevo TQ Absolute XR Mass Spectrometer, the industry can accelerate drug development processes while maintaining the highest standards of quality and precision. Alderley Analytical’s commitment to extreme robustness in bioanalysis sets a new standard for the field, opening up opportunities for more accurate and reliable biomarker analysis in plasma samples. As the demand for advanced bioanalytical services continues to grow, innovative solutions like those offered by Alderley Analytical play a crucial role in advancing research and ensuring the safety and efficacy of new therapeutic treatments.
Read more from the-scientist.com
